401 related articles for article (PubMed ID: 11896572)
1. Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.
Tian H; Faje AT; Lee SL; Jorgensen TJ
Neoplasia; 2002; 4(2):171-80. PubMed ID: 11896572
[TBL] [Abstract][Full Text] [Related]
2. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
3. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
[TBL] [Abstract][Full Text] [Related]
4. Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest.
Levesque AA; Fanous AA; Poh A; Eastman A
Mol Cancer Ther; 2008 Feb; 7(2):252-62. PubMed ID: 18281511
[TBL] [Abstract][Full Text] [Related]
5. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
6. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
7. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
8. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest.
Wang XQ; Stanbridge EJ; Lao X; Cai Q; Fan ST; Redpath JL
Radiat Res; 2007 Dec; 168(6):706-15. PubMed ID: 18088187
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
Hirose Y; Berger MS; Pieper RO
Cancer Res; 2001 Aug; 61(15):5843-9. PubMed ID: 11479224
[TBL] [Abstract][Full Text] [Related]
10. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
Guo N; Faller DV; Vaziri C
Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
[TBL] [Abstract][Full Text] [Related]
11. A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.
Eastman A; Kohn EA; Brown MK; Rathman J; Livingstone M; Blank DH; Gribble GW
Mol Cancer Ther; 2002 Oct; 1(12):1067-78. PubMed ID: 12481430
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
13. Cadmium-induced DNA damage triggers G(2)/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells.
Bork U; Lee WK; Kuchler A; Dittmar T; Thévenod F
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F255-65. PubMed ID: 19923412
[TBL] [Abstract][Full Text] [Related]
14. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.
Graves PR; Yu L; Schwarz JK; Gales J; Sausville EA; O'Connor PM; Piwnica-Worms H
J Biol Chem; 2000 Feb; 275(8):5600-5. PubMed ID: 10681541
[TBL] [Abstract][Full Text] [Related]
15. Caffeine and human DNA metabolism: the magic and the mystery.
Kaufmann WK; Heffernan TP; Beaulieu LM; Doherty S; Frank AR; Zhou Y; Bryant MF; Zhou T; Luche DD; Nikolaishvili-Feinberg N; Simpson DA; Cordeiro-Stone M
Mutat Res; 2003 Nov; 532(1-2):85-102. PubMed ID: 14643431
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Sampath D; Shi Z; Plunkett W
Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
[TBL] [Abstract][Full Text] [Related]
17. Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism.
Luo Y; Rockow-Magnone SK; Kroeger PE; Frost L; Chen Z; Han EK; Ng SC; Simmer RL; Giranda VL
Neoplasia; 2001; 3(5):411-9. PubMed ID: 11687952
[TBL] [Abstract][Full Text] [Related]
18. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
[TBL] [Abstract][Full Text] [Related]
19. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
Wu G; Lin N; Xu L; Liu B; Feitelson MA
BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.
Koniaras K; Cuddihy AR; Christopoulos H; Hogg A; O'Connell MJ
Oncogene; 2001 Nov; 20(51):7453-63. PubMed ID: 11709716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
